Back
Collegium Pharmaceutical Vs. AnaptysBio Industry Stock Comparison
Buy
64
COLL
Collegium Pharmaceutical
Last Price:
38.09
Seasonality Move:
-1.07%
Buy
66
ANAB
AnaptysBio
Last Price:
25.75
Seasonality Move:
-10.22%
Buy
64
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $38.06. The Score for COLL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- COLL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $25.75. The Score for ANAB is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $38.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $25.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANAB is experiencing slight buying pressure.
COLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 58.26 | Buy |
| Chaikin Money Flow: | 186028 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.33 - 38.33) | Buy |
| Bollinger Bands (100): | (32.04 - 38.02) | Buy |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 63.32 | Buy |
| Chaikin Money Flow: | 78051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.82 - 24.8) | Buy |
| Bollinger Bands (100): | (20.89 - 24.91) | Buy |
COLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.35 | Buy |
| 20-day SMA: | 36.25 | Buy |
| 50-day SMA: | 37.56 | Buy |
| 200-day SMA: | 29.31 | Buy |
| 8-day EMA: | 37.27 | Buy |
| 20-day EMA: | 37 | Buy |
| 50-day EMA: | 36.56 | Buy |
| 200-day EMA: | 31.13 | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.22 | Buy |
| 20-day SMA: | 22.55 | Buy |
| 50-day SMA: | 22.97 | Buy |
| 200-day SMA: | 20.33 | Buy |
| 8-day EMA: | 24.89 | Buy |
| 20-day EMA: | 23.4 | Buy |
| 50-day EMA: | 22.82 | Buy |
| 200-day EMA: | 21.57 | Buy |
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.05 per share, an increase this year of $0.80 per share, and an increase next year of $0.64 per share.
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.21 per share, and an increase next year of $0.76 per share.
Collegium Pharmaceutical Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||